Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.4050
0.00 (0.00%)
Jul 14, 2026, 2:49 PM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 11.07 million as of July 14, 2026. Its market cap has increased by 113.72% in one year.
Market Cap
11.07M
Enterprise Value
10.71M
Revenue
668.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 11.07M, an increase of 38.93%. That is a compound annual growth rate of 15.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 11.07M | 2.54% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EZZ Life Science Holdings | 21.18M |
| Argenica Therapeutics | 16.06M |
| Immuron | 14.05M |
| ReNerve | 13.78M |
| AdAlta | 11.90M |
| Vectus Biosystems | 9.84M |
| Invex Therapeutics | 7.89M |
| Tissue Repair | 6.65M |